From October 1, 2023 to December 31, 2023, the company has repurchased 17,500 shares, representing 1.26% for $0.08 million. With this, the company has completed the repurchase of 57,500 shares, representing 4.05% for $0.27 million under the buyback announced on June 12, 2023.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.45 USD | +2.53% | +2.30% | -3.47% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.47% | 6.04M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Tranche Update on Creative Medical Technology Holdings, Inc.'s Equity Buyback Plan announced on June 12, 2023.